Calmedica
Calmedica provides SMS/RCS-based conversational AI patient follow-up solutions for French hospitals and clinics, serving 200+ establishments with its memoQuest platform and add-on modules for telemonitoring, no-show management, and satisfaction analysis.
- Company typePrivate
- Founded2013
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Calmedica does
Calmedica is a Paris-based private telehealth company founded in 2013 by Dr. Corinne Segalen and engineer Alexis Hernot (École Polytechnique, INSEAD) that provides SMS/RCS-based conversational AI solutions for patient follow-up in healthcare establishments. Its core platform, memoQuest, automates bidirectional patient communication before and after medical care without requiring app downloads, achieving 95% patient response rates versus 60% for traditional phone outreach. The company operates a modular suite including memoMatrix (a Class IIa medical device for specialty telemonitoring), memoSwap (no-show and cancellation management with 60% slot reallocation), and qualiQuest (AI-powered patient satisfaction analysis with IFAQ financial valorization), all integrated with hospital information systems via HL7, FHIR, secure APIs, and EAI connectors.
The platform serves 200+ healthcare establishments across France, including marquee logos such as AP-HP (deployed across 23 ambulatory surgery units), Unicancer, CHU de Rennes, CHU de Tours, Ramsay Santé, Vivalto Santé, and Groupe Hospitalier Paris Saint-Joseph. Calmedica is certified ISO 27001 (Bureau Veritas, 2025) and operates HDS-compliant health data hosting entirely within France/EEA, with GDPR-compliant processing. The company sells through direct enterprise field sales and is referenced via French public hospital group purchasing organizations (UniHA, RESAH, CAIH), with pricing on quote-based annual SaaS subscriptions tied to establishment size and module selection. In May 2024, Calmedica acquired competitor DirectoSanté (developer of DirectoSuivi) to expand its post-hospital telemonitoring portfolio and customer base, while pursuing SecNumCloud certification expected in 2026.
Calmedica firmographics
Firmographics- Name
- Calmedica
- Legal name
- SAS CALMEDICA
- Website
- https://calmedica.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Calmedica provides SMS/RCS-based conversational AI patient follow-up solutions for French hospitals and clinics, serving 200+ establishments with its memoQuest platform and add-on modules for telemonitoring, no-show management, and satisfaction analysis.
- Ownership category
- akta.pro rank
Calmedica industry classification
Industry- Product category
- Healthcare Telemonitoring Software
- NAICS
- All Other Outpatient Care Centers (621498)
- SIC
- Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)
- akta.pro secondary industries
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD), Nurse Triage & Clinical Call-Center Teletriage Platforms (HLALAJAC)
Keywords
Where Calmedica is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Calmedica business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- SaaS Subscription - memoQuest Platform: Subscription-based SaaS platform providing patient follow-up services to healthcare establishments. Sold as modular platform with core memoQuest chatbot plus optional add-ons (memoMatrix, memoSwap, qualiQuest). Revenue derived from per-establishment licensing with configurable modules.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Quote-based enterprise pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Calmedica product offering
Product offeringCore offering
Calmedica provides an SMS/RCS conversational AI platform for healthcare establishments to automate patient follow-up before and after medical care. The modular platform comprises memoQuest (core tele-follow-up chatbot), memoMatrix (Class IIa medical device telemonitoring), memoSwap (cancellation and no-show slot reallocation), and qualiQuest (AI-driven patient satisfaction analysis), all integrated with hospital information systems (SIH/DPI). It is sold primarily to French public and private hospitals to replace manual phone-based follow-up.
Product overview
Calmedica offers a unified platform with modular architecture centered on memoQuest, its core patient follow-up solution. The platform integrates four modules: memoMatrix (Class IIa medical device for advanced specialty monitoring), memoSwap (intelligent slot/cancellation management), and qualiQuest (AI-powered patient satisfaction analysis). The modules share the same conversational SMS/RCS infrastructure and integrate with hospital DPI systems. Calmedica acquired DirectoSanté's DirectoSuivi in 2024 to expand its telemonitoring portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- memoQuest: Patient follow-up solution via SMS and RCS conversational robot for dialogue with patients before and after medical care.
- memoMatrix
- memoSwap
- qualiQuest
Products and services
- memoQuest Conversational SMS/RCS chatbot that automates patient dialogue before and after medical care. Reaches all patients regardless of age or digital literacy without requiring app downloads; achieves a 95% patient response rate. Includes a voice callbot for patients unreachable by text.
- memoMatrix Advanced telemonitoring medical device classified as Class IIa software. Provides refined, specialty-tailored patient monitoring capabilities that go beyond the base memoQuest platform.
- memoSwap Intelligent cancellation and no-show management module that anticipates procedure cancellations and automatically reallocates freed slots to operating rooms or technical platforms. Achieved 60% slot recovery and 46% reduction in same-day (J0) cancellations in a French CHU.
- qualiQuest Patient satisfaction 'hot' measurement module that sends conversational SMS/RCS after discharge to collect satisfaction and qualitative comments. Uses AI to categorize verbatims across administrative, communication, hospitality, medical, organizational, and relational themes and produces actionable improvement axes.
- DirectoSuivi Post-hospital telemonitoring solution originally developed by DirectoSanté. Brought into Calmedica's portfolio through the May 2024 acquisition, expanding the company's customer base and feature set in post-hospital telemonitoring.
Quantifiable outcome
- 95% patient response rate vs 60% for traditional phone surveys
- +6 more outcomes
Companies that use Calmedica
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
Calmedica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability5 records
Feature5 records
Calmedica partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered major and core.
- DirectoSantémajorCalmedica acquired DirectoSanté activities on May 14, 2024. DirectoSanté developed DirectoSuivi solution. The acquisition strengthens Calmedica's market position in post-hospital telemonitoring by expanding its customer base and diversifying features.
- UniHAcoreUniHA, the leading cooperative group purchasing organization for French public hospitals, selected Calmedica's memoQuest for its 'Gestion du parcours patient' (Patient Pathway Management) offering in May 2021. This provides Calmedica access to procurement through UniHA's member hospitals.
- Assurance MaladiemajorCalmedica collaborated with Assurance Maladie (French National Health Insurance) for COVID-19 patient contact tracing since January 2021. Since 2018, Calmedica has partnered on PRADO, the post-hospitalization home return assistance service.
- RESAHcoreRESAH (Réseau des Acheteurs Hospitaliers) is referenced alongside UniHA as a group purchasing organization through which Calmedica solutions are available to public healthcare establishments.
- CAIHcoreCAIH is referenced as a purchasing group through which Calmedica solutions are available to healthcare establishments.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Calmedica competitors and assessment
Company assessmentDirect peers
- Lifen: French health-data interoperability platform enabling secure document exchange between hospitals and physicians. Directly comparable as a hospital-facing interoperability and patient-communication SaaS layer in the French healthcare ecosystem.
- Voluntis: France-based digital therapeutics and remote patient monitoring platform. Directly comparable as a French RPM/digital-therapeutics company targeting chronic disease management with software-as-a-medical-device positioning similar to Calmedica's memoMatrix Class IIa.
Emerging players
- Continuum+: French remote-monitoring startup focused on chronic patient telemonitoring at home. Comparable as a French RPM competitor with similar patient-pathway and post-hospitalization monitoring use cases to Calmedica's memoMatrix module.
- Posos: French clinical AI assistant for healthcare professionals. Comparable as a French AI-in-healthcare vendor applying NLP to clinical workflows, with potential overlap on the verbatim-analysis and clinical-decision-support capabilities adjacent to Calmedica's AI modules.
- H4D (Health for Development): French telehealth company providing teleconsultation booths and remote care solutions. Comparable as a French telehealth specialist addressing healthcare-establishment and patient-monitoring use cases adjacent to Calmedica's telemonitoring core.
Broad incumbents
- Doctolib: France's dominant telehealth and appointment-booking platform with millions of users. Comparable as a French healthcare SaaS provider serving hospitals and patients, with overlapping teleconsultation and patient-engagement ambitions though broader in scope.
- Dedalus: Major European hospital information system (HIS/EHR) vendor with deep presence in France (Orbis DPI). Comparable because Dedalus owns one of the DPI systems (Orbis) that Calmedica integrates with and could compete with by bundling patient-engagement features.
- Cegedim: French healthcare software and data group serving physicians, hospitals, and insurers. Comparable as a long-standing French healthcare-software incumbent that could expand into RPM and patient-engagement adjacent to Calmedica's space.
- Maincare Solutions: French hospital IT vendor providing DPI and patient pathway solutions. Comparable as a French hospital-software incumbent whose products overlap with parts of Calmedica's pathway-management and patient-engagement scope.
Regional players
- Tessan: French telemedicine-kiosk and remote-consultation provider deployed in pharmacies and healthcare establishments. Comparable as a French telehealth deployment targeting patient-facing access points in similar healthcare-facility settings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Calmedica social profiles
Digital presenceCalmedica compliance and trust
Trust signalCompliance4 records
Calmedica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Calmedica leadership team
Management profileNumber of profiles
Profiles5 records
Calmedica subsidiaries and ownership
Company hierarchySubsidiaries1 record
Calmedica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Calmedica M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Calmedica
What does Calmedica do?
Calmedica provides an SMS/RCS conversational AI platform for healthcare establishments to automate patient follow-up before and after medical care. The modular platform comprises memoQuest (core tele-follow-up chatbot), memoMatrix (Class IIa medical device telemonitoring), memoSwap (cancellation and no-show slot reallocation), and qualiQuest (AI-driven patient satisfaction analysis), all integrated with hospital information systems (SIH/DPI). It is sold primarily to French public and private hospitals to replace manual phone-based follow-up.
Is Calmedica a public or private company?
Calmedica is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Calmedica founded?
Calmedica was founded in 2013. It employs 1 to 10 people.
Where is Calmedica based?
Calmedica is headquartered in Paris, France, in the Europe region.
How does Calmedica make money?
One revenue line is on record: saaS Subscription - memoQuest Platform.
Who are Calmedica's main competitors?
Direct peers on record are Lifen and Voluntis. Emerging players are Continuum+, Posos and H4D (Health for Development). Broad incumbents are Doctolib, Dedalus, Cegedim and Maincare Solutions. Tessan is listed as a regional player.
Does Calmedica have an API?
No public API is recorded for Calmedica.
What industry is Calmedica in?
Calmedica's product category is Healthcare Telemonitoring Software. Its primary akta.pro industry code is HLACAFAH, Virtual Nursing, Telemonitoring & Command Center Platforms, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 621498 and its SIC code is 7372.